Cubist Pharmaceuticals to Present at the CIBC Healthcare Conference
12:07p ET October 25, 2007 (Business Wire)
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that David McGirr, SVP and CFO will present on Monday, November 5th, at 9:10 A.M. ET at the CIBC World Markets 18th Annual Healthcare Conference being held at the Waldorf-Astoria Hotel in New York City. This presentation will include a discussion of the company's business activities, financial outlook, and current news.
A live webcast of the presentation will be accessible through Cubist's website at www.cubist.com in the Investor Relations Conference Calendar section. The presentation will be archived there as well and available after the event for a period of 14 days.
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. The Cubist product pipeline includes pre-clinical programs that address unmet medical need in Gram-positive infections, Gram-negative infections, and CDAD (Clostridium difficile-associated diarrhea). Cubist is headquartered in Lexington, MA. Additional information can be found at Cubist's web site at www.cubist.com.
Cubist and CUBICIN are registered trademarks of Cubist Pharmaceuticals, Inc.
SOURCE: Cubist Pharmaceuticals
Cubist Pharmaceuticals, Inc. Eileen C. McIntyre, 781-860-8533 Senior Director, Corporate Communications eileen.mcintyre@cubist.com
Send stock manipulators to: enforcement@sec.gov-and to jail.
